AGENDA | DECEMBER 9

1:00 - 1:05 PM

Welcome and Opening Remarks

Presented By:
William J. Link, PhD, Managing Partner - Flying L Partners

1:05 - 1:50 PM

2020 Ophthalmology Year in Review Presentations

FDA Approvals
Presented By:
Patrick Healy, MPH, Co-Founder - Trial Runners

Private Funding Trends
Presented By:
Jonathan Norris, Managing Director, Healthcare Practice - Silicon Valley Bank

Public Market Highlights and M&A Activity
Presented By:
Udit Patel, Executive Director, Healthcare Investment Banking - Piper Sandler

1:50 - 2:30 PM

Year in Review - Investor Perspectives

Participants:
Arjun Arora, Director - KKR
Ali Behbahani, MD, General Partner - NEA
Anat Naschitz, Managing Director - OrbiMed
Bruce Robertson, Managing Director - H.I.G. Capital
Jeffry Weinhuff, Managing Partner - Visionary Venture Fund

Moderated By:
William J. Link, PhD, Managing Partner - Flying L Partners

2:30 - 3:10 PM

Year in Review - Clinical Perspectives

Participants:
Uday Devgan, MD - Devgan Eye Surgery/Clinical Professor - UCLA
Nicole Fram, MD, Managing Partner - Advanced Vision Care
Paul Karpecki, OD, FAAO, Associate Professor - UPike College of Optometry/Kentucky Eye Institute
Stephen Schwartz, MD, Chief of Retina Division - Jules Stein Eye Institute, UCLA
Robert N. Weinreb, MD, Director, Shiley Eye Institute/Distinguished Professor and Chair, Ophthalmology/Distinguished Professor, Bioengineering/Director, Hamilton Glaucoma Center - University of California, San Diego

Moderated By:
Firas M. Rahhal, MD, Partner, Retina Vitreous Associates and Exsight Ventures/Associate Clinical Professor, UCLA

3:10 - 3:50 PM

Year in Review - Industry Perspectives

Participants:
Laurent Attias, SVP, Corporate Development Strategy, BD&L and M&A - Alcon
Andrew Chang, Head of Global Sales, Ophthalmic Devices and President - Carl Zeiss Meditec
Mark Hagler, SVP, Head of Ophthalmics, Oncology & LTC - Sun Pharma
Robert Kissling, MD, VP, Medical Affairs - Bausch + Lomb
Nikki Sidi, VP, Global Strategic Marketing - Johnson & Johnson Vision

Moderated By:
Robert Rothman, MD, Partner at OCLI/Glaucoma Consultants of Long Island Founding Partner and Principal of InFocus Capital Partners

3:50 - 4:00 PM

Closing Remarks

THANK YOU TO OUR 2020 SPONSORS